Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-03-22 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (RNS Number : 8982T) from PureTech Health PLC, dated March 22, 2023. The title explicitly states 'Transaction in Own Shares'. The content details the purchase of ordinary shares as part of a 'Share Buyback Programme' and provides specific transaction data (date, volume, price). This directly matches the definition for 'Transaction in Own Shares' (Code: POS).
2023-03-22 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 5902T') from PureTech Health PLC dated March 21, 2023. The title explicitly states 'Transaction in Own Shares'. The content details the purchase of ordinary shares as part of a 'Share Buyback Programme' and provides specific transaction data (date, volume, prices). This directly matches the definition for 'Transaction in Own Shares', which corresponds to the filing type code POS (Report of the company buying back or selling its own shares (share repurchase/issuance)). Although it is an RNS filing, the specific nature of the transaction (share repurchase) makes POS the most accurate classification over the general RNS fallback.
2023-03-21 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It contains a press release about positive Phase 3 trial results for a drug, which is typical content for a 6-K filing. The document is short (1807 characters) and primarily serves as a regulatory announcement of a press release rather than a full financial or management report. It does not contain detailed financial statements or comprehensive analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2023-03-20 English
Karuna 2nd Successful Ph3 Study in Schizophrenia
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number (5441T) and the date (20 March 2023), indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS) system, common in the UK/LSE market. The content details positive Phase 3 trial results for a drug (KarXT) developed by a company PureTech Health PLC's founded entity, Karuna Therapeutics. This is a press release announcing significant clinical trial data and upcoming regulatory steps (NDA submission). Since it is an announcement of material information released through a regulatory channel, and it is not a full financial report (like 10-K or IR), nor a specific management change or dividend notice, the most appropriate classification is the general regulatory announcement category, RNS. The document length is substantial (over 20k characters), so it is not a simple RPA (Report Publication Announcement).
2023-03-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme', including the date, volume, and price range of the transactions. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares.
2023-03-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC dated March 17, 2023. The title explicitly states 'Transaction in Own Shares' and the content details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS).
2023-03-17 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.